![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Urquima S.a. Palau-solità I Plegamans Es, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Rupatadine fumarate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2017-202 - Rev 00
This Chemical Type CEP, issued on August 09, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2888 associated with this CEP further emphasizes